(H-Cys-OtBu)2 · 2 HCl

(H-Cys-OtBu)2 · 2 HCl is a protected cysteine derivative supplied as a bis(tert-butyl) thioether-protected cystine-like building block in the form of the dihydrochloride salt. The presence of cysteine thiol protection and hydrochloride counterions makes it a practical intermediate for preparing sulfur-containing peptide segments and for downstream conversion to thiol-reactive cysteine derivatives under controlled deprotection conditions. Researchers in peptide chemistry and medicinal chemistry rely on this protected format to manage cysteine chemoselectivity during assembly and to support reproducible handling of sulfur-containing functionality.

1. Cysteine-Containing Peptide Segments

(H-Cys-OtBu)2 · 2 HCl is used to introduce cysteine residues into peptide synthesis workflows where thiol chemoselectivity is required during coupling and deprotection steps. Peptide synthesis groups commonly incorporate cysteine-containing segments to build disulfide-linked motifs, redox-sensitive linkers, or cysteine-rich sequences for structure-function studies. The tert-butyl-protected sulfur functionality helps minimize undesired thiol oxidation and side reactions during iterative assembly, supporting cleaner synthesis of sulfur-containing peptides that would otherwise be difficult to handle as free thiols. This protected, salt-form reagent is also favored when peptide assembly is performed in environments where thiols would be prone to oxidation or uncontrolled reactivity.

2. Disulfide Motif Building Blocks

(H-Cys-OtBu)2 · 2 HCl is applied as a cysteine-protecting building block for preparing peptide and peptidomimetic constructs that require controlled formation of disulfide bonds or disulfide-adjacent architectures. Chemical biology and medicinal chemistry teams use cysteine-derived intermediates to generate defined redox states in peptide scaffolds used for binding studies, stability screening, and conformational investigations. Because the sulfur functionality is protected in the supplied form, researchers can assemble larger sequences without premature thiol crosslinking, then convert to the appropriate reactive cysteine state at the stage needed for disulfide formation. This makes the reagent particularly useful for workflows where disulfide connectivity and reproducibility are critical to downstream analytical characterization.

3. Pharmaceutical Intermediate Synthesis

(H-Cys-OtBu)2 · 2 HCl serves as a sulfur-containing protected intermediate for medicinal chemistry and process development programs that require cysteine functionality as a building block for larger heteroatom-rich fragments. Pharmaceutical intermediate development teams use protected cysteine derivatives to construct side-chain motifs in peptidomimetic structures, to prepare protected thiol intermediates for further functionalization, or to support late-stage derivatization strategies that depend on controlled reactivity. The dihydrochloride salt form improves handling and storage characteristics for many protected amino acid intermediates, while the tert-butyl-protected sulfur helps keep the intermediate stable against oxidation during multi-step synthesis. This positioning aligns with industrial and scale-up needs where chemoselective control of sulfur functionality is a key driver for reliable manufacturing of downstream targets.

1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

3. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

4. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

5. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line